---
figid: PMC7998891__cancers-13-01323-g006
figtitle: Molecular components of BCG-driven inflammation in bladder cancer microenvironment
organisms:
- NA
pmcid: PMC7998891
filename: cancers-13-01323-g006.jpg
figlink: pmc/articles/PMC7998891/figure/cancers-13-01323-f006/
number: F6
caption: The molecular components of BCG-driven inflammation in bladder cancer microenvironment.
  BCG activates NFκB/TNFα signaling pathway which is responsible for the induction
  of CTL-promoting cytokines (CXCL9 and CXCL10), but also triggers the suppressive
  COX2/PGE2/EP4 pathway which includes MDSC/Treg-attracting chemokines (CXCL8 and
  CCL22) and additional immunosuppressive inflammatory mediators (IDO1 and IL-10).
  Combining BCG with indomethacin, celecoxib or EP4 blockade selectively enhances
  the CTL attraction but eliminates the PGE2 dependent suppressive factors, favoring
  antitumor immunity.
papertitle: NFκB-Activated COX2/PGE2/EP4 Axis Controls the Magnitude and Selectivity
  of BCG-Induced Inflammation in Human Bladder Cancer Tissues.
reftext: Omar M. Ibrahim, et al. Cancers (Basel). 2021 Mar;13(6):1323.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6485329
figid_alias: PMC7998891__F6
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7998891__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7998891__cancers-13-01323-g006.html
  '@type': Dataset
  description: The molecular components of BCG-driven inflammation in bladder cancer
    microenvironment. BCG activates NFκB/TNFα signaling pathway which is responsible
    for the induction of CTL-promoting cytokines (CXCL9 and CXCL10), but also triggers
    the suppressive COX2/PGE2/EP4 pathway which includes MDSC/Treg-attracting chemokines
    (CXCL8 and CCL22) and additional immunosuppressive inflammatory mediators (IDO1
    and IL-10). Combining BCG with indomethacin, celecoxib or EP4 blockade selectively
    enhances the CTL attraction but eliminates the PGE2 dependent suppressive factors,
    favoring antitumor immunity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PTGER4
  - COX2
  - PTGS2
  - MTCO2P12
  - TNF
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - CXCL9
  - CXCL8
  - IDO1
  - CXCL10
  - CCL22
  - IL10
  - CXCR1
  - CXCR3
  - CCR4
  - CNOT6
  - PGE
  - tumor
---
